Branched-chain amino acid transaminase 2 (BCAT2) plays a critical role in the metabolism of branched-chain amino acids (BCAAs) such as leucine, isoleucine, and valine, which are essential nutrients integral to protein synthesis and energy production in the body. BCAT2 is predominantly found in the mitochondria of tissues with high metabolic rates, including the muscles and brain, where it catalyzes the first step in BCAA catabolism. Given its central role in metabolism, the expression of BCAT2 is tightly regulated and can be influenced by various biochemical signals and dietary components that reflect the body's metabolic state. Factors that elevate the need for energy production or protein synthesis can signal the need to upregulate BCAT2 expression. For example, states of increased energy demand or specific nutritional cues can trigger intracellular pathways that enhance the transcription of the BCAT2 gene.
Several non-protein chemical compounds have been identified as potential inducers of BCAT2 expression, acting through distinct molecular mechanisms. For instance, compounds that activate AMP-activated protein kinase (AMPK), such as AICAR and metformin, can signal cellular energy deficit, leading to an adaptive response that includes the induction of BCAT2 expression to promote energy generation from BCAAs. Similarly, PPAR agonists, like those activating PPARδ and PPARα, can elicit a transcriptional response that elevates the expression of genes involved in fatty acid metabolism and may extend to the upregulation of BCAT2, reflecting a broader adjustment to the metabolic machinery of the cell. Antioxidant molecules such as resveratrol and epigallocatechin gallate (EGCG) from green tea may also prompt an increase in BCAT2 expression as part of the cellular adaptation to oxidative stress. Furthermore, dietary components like hydroxycitric acid and beta-hydroxy beta-methylbutyric acid (HMB) might stimulate BCAT2 transcription by signaling shifts in nutrient availability. Lastly, epigenetic modulators, including but not limited to sodium butyrate and compounds that influence DNA methylation and histone acetylation, may also play a role in remodeling the chromatin landscape around the BCAT2 gene, thereby enhancing its transcriptional activity. Collectively, these compounds could induce BCAT2 expression through a converging network of signaling pathways that reflect the intricate regulation of energy and amino acid metabolism within cells.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
AICAR can activate AMP-activated protein kinase (AMPK), which may then upregulate BCAT2 expression as a compensatory response to increased cellular energy demands during metabolic stress. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $80.00 $175.00 | 28 | |
A PPARδ agonist like GW501516 (Cardarine) can initiate the transcription of genes involved in energy utilization, which may include the upregulation of BCAT2 to facilitate enhanced fatty acid metabolism. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Metformin's activation of AMPK could lead to an upsurge in BCAT2 expression, potentially optimizing the catabolism of branched-chain amino acids in response to improved glucose uptake and utilization. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol may activate sirtuin pathways that lead to an increase in BCAT2 expression, potentially as part of a broader cellular response to oxidative stress and caloric restriction. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
Fenofibrate, by triggering PPARα, could initiate a cascade of gene expression that includes the upregulation of BCAT2, possibly to manage lipid and amino acid metabolism concurrently. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG may exert its influence by promoting DNA hypomethylation or histone acetylation, which can lead to an increase in BCAT2 expression as part of a response to dietary polyphenols. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin could enhance BCAT2 expression through the activation of transcriptional pathways tied to cellular defense mechanisms against oxidative conditions. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
Sodium butyrate, by inhibiting histone deacetylases, may create a more accessible chromatin structure around the BCAT2 gene, leading to its increased transcription and expression. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $92.00 $206.00 $1744.00 $7864.00 $16330.00 | 11 | |
DHA may upregulate BCAT2 expression through alteration of the cellular membrane composition and signaling pathways that govern energy metabolism and inflammation. |